Evidence map›Paper›PMID 40567787›Full record

ArticlePeerJ. Computer science2025

A feature selection method utilizing path accumulation cost, redundancy minimization, and interaction maximization for the diagnosis of coronary heart disease.

Jiayao Jiang, Zheng Yue, Hongling Zhu, Yan Wang, Hongsen Cai, Wenguang Hou

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiayao Jiang *School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Zheng Yue *School of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Hongling ZhuDivision of Cardiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Yan WangDivision of Cardiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0003-2046-7604
Hongsen CaiSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Wenguang HouSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronary heart disease (CHD) is a major cause of mortality worldwide, with an increasing trend of affecting younger populations. The asymptomatic early stages and rapid progression of CHD make diagnosis challenging, necessitating efficient diagnostic approaches. Methods: We propose a novel algorithm that focuses on accumulating soft path costs to discern crucial indicators from extensive diagnostic tests, aiming to improve early CHD identification. Our approach emphasizes feature interaction using an interaction accumulation evaluation function to identify features with maximal interaction and minimal redundancy. A new stopping criterion based on information gain ratio is also introduced. Results: Experimental outcomes demonstrate that our algorithm outperforms several classical algorithms in terms of classification accuracy and feature dimension reduction, while also identifying highly correlated feature subsets. Conclusion: The proposed approach offers an efficient solution for early detection of CHD by identifying critical indicators, reducing diagnostic complexity, and improving predictive accuracy, thus potentially leading to more effective CHD management.

Indexed as

Coronary artery diseaseFeature redundancyFeature relevanceFeature selectionInteraction information

Identifiers

PMID40567787
PMCPMC12190288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.